This observation is consistent with a previous study where deletion of the KRAS.G13D mutation from the endogenous locus of the human colorectal adenocarcinoma cell line, HCT116, results in an increase in paxillin structures (37). Here, KRAS is linked to colorectal adenocarcinoma.